|
Figure 1A Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.12 |
.001 |
H/R |
1 |
3 |
0.41 |
0.05 |
|
|
|
|
|
|
|
Figure 1B Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
1.00 |
0.13 |
<0 |
miR-615-3p |
1 |
3 |
11.00 |
1.10 |
|
|
|
|
|
|
|
Figure 1C Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.80 |
0.20 |
< 0 |
H/R |
1 |
3 |
0.90 |
0.11 |
NC mimics |
1 |
3 |
0.80 |
0.10 |
.001 |
miR-615-3p |
1 |
3 |
1.60 |
0.18 |
|
|
|
|
|
|
|
Figure 1E Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
5.41 |
0.55 |
< 0 |
H/R |
1 |
3 |
15.81 |
0.89 |
NC mimics |
1 |
3 |
17.11 |
0.48 |
< 0 |
miR-615-3p |
1 |
3 |
9.82 |
0.85 |
|
|
|
|
|
|
|
Figure 1G Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
2.20 |
0.23 |
.001 |
H/R |
1 |
3 |
4.50 |
0.51 |
NC mimics |
1 |
3 |
4.70 |
0.52 |
.015 |
miR-615-3p |
1 |
3 |
3.30 |
0.35 |
|
|
|
|
|
|
|
Figure 1H Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
60.00 |
6.20 |
.001 |
H/R |
1 |
3 |
35.00 |
3.62 |
NC mimics |
1 |
3 |
36.00 |
3.70 |
.005 |
miR-615-3p |
1 |
3 |
56.00 |
5.66 |
|
|
|
|
|
|
|
Figure 1I Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
2.20 |
0.24 |
.001 |
H/R |
1 |
3 |
4.20 |
0.45 |
NC mimics |
1 |
3 |
4.40 |
0.46 |
.038 |
miR-615-3p |
1 |
3 |
3.30 |
0.40 |
|
|
|
|
|
|
|
Figure 2A Experimental Results |
PSMD11 |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.11 |
.372 |
H/R |
1 |
3 |
0.92 |
0.09 |
|
|
|
|
|
|
ZNF626 |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.10 |
.294 |
H/R |
1 |
3 |
0.90 |
0.10 |
|
|
|
|
|
|
ITSN1 |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.09 |
.681 |
H/R |
1 |
3 |
0.96 |
0.11 |
|
|
|
|
|
|
MEF2A |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.11 |
< 0 |
H/R |
1 |
3 |
3.33 |
0.35 |
|
|
|
|
|
|
USP44 |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.09 |
.336 |
H/R |
1 |
3 |
1.10 |
0.13 |
|
|
|
|
|
|
TOMM7 |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.12 |
.839 |
H/R |
1 |
3 |
0.98 |
0.10 |
|
|
|
|
|
|
|
Figure 2E Experimental Results |
Wt |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
1.00 |
0.11 |
.001 |
miR-615-3p |
1 |
3 |
0.43 |
0.05 |
|
|
|
|
|
|
Mut |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
1.00 |
0.09 |
.72 |
miR-615-3p |
1 |
3 |
0.97 |
0.10 |
|
|
|
|
|
|
|
Figure 2F Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
1.00 |
0.11 |
.002 |
miR-615-3p |
1 |
3 |
0.46 |
0.05 |
|
|
|
|
|
|
|
Figure 3A Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
1.00 |
0.10 |
|
miR-615-3p |
1 |
3 |
0.43 |
0.05 |
.007 |
miR-615-3p+MEF2A |
1 |
3 |
2.14 |
0.22 |
< 0 |
|
|
|
|
|
|
|
Figure 3C Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
0.50 |
0.06 |
|
miR-615-3p |
1 |
3 |
1.05 |
0.11 |
< 0 |
miR-615-3p+MEF2A |
1 |
3 |
0.66 |
0.07 |
.003 |
|
|
|
|
|
|
|
Figure 3E Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
14.71 |
0.62 |
|
miR-615-3p |
1 |
3 |
6.04 |
0.37 |
< 0 |
miR-615-3p+MEF2A |
1 |
3 |
13.31 |
0.40 |
< 0 |
|
|
|
|
|
|
|
Figure 3G Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
4.20 |
0.45 |
|
miR-615-3p |
1 |
3 |
2.50 |
0.03 |
.002 |
miR-615-3p+MEF2A |
1 |
3 |
3.70 |
0.38 |
.012 |
|
|
|
|
|
|
|
Figure 3H Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
26.10 |
2.65 |
|
miR-615-3p |
1 |
3 |
44.30 |
4.45 |
.002 |
miR-615-3p+MEF2A |
1 |
3 |
31.00 |
3.89 |
.011 |
|
|
|
|
|
|
|
Figure 3I Experimental Results |
|
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
NC mimics |
1 |
3 |
3.90 |
0.40 |
|
miR-615-3p |
1 |
3 |
2.20 |
0.34 |
.003 |
miR-615-3p+MEF2A |
1 |
3 |
3.50 |
0.36 |
.012 |
|
|
|
|
|
|
|
Figure 4A Experimental Results |
p-PI3K/PI3K |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1.00 |
0.12 |
|
H/R |
1 |
3 |
2.34 |
0.17 |
< 0 |
NC mimics |
1 |
3 |
2.37 |
0.20 |
|
miR-615-3p |
1 |
3 |
1.35 |
0.11 |
0 |
miR-615-3p+MEF2A |
1 |
3 |
1.89 |
0.15 |
.01 |
|
|
|
|
|
|
p-Akt/Akt |
n (Trials/Sample Size) |
r (Replication Size) |
Mean |
Standard Deviation |
P
|
Control |
1 |
3 |
1 |
0.1 |
|
H/R |
1 |
3 |
2.69 |
0.31 |
< 0 |
NC mimics |
1 |
3 |
2.75 |
0.29 |
|
miR-615-3p |
1 |
3 |
1.30 |
0.11 |
0 |
miR-615-3p+MEF2A |
1 |
3 |
2.05 |
0.17 |
.011 |